You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 272 Use of LioCyx-M, autologous hepatitis B virus (HBV)-Specific T cell receptor (TCR) T-cells, in advanced HBV-related hepatocellular carcinoma (HCC)

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
272 Use of LioCyx-M, autologous hepatitis B virus (HBV)-Specific T cell receptor (TCR) T-cells, in advanced HBV-related hepatocellular carcinoma (HCC)

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 2020196018
Dec 202034010
Jan 202169012
Feb 202168010
Mar 2021100012
Apr 202174013
May 20211006
Jun 2021008
Jul 20210012
Aug 2021003
Sep 20210015
Oct 202144022
Nov 202176017
Dec 20213408
Jan 20229207
Feb 20222604
Mar 20227008
Apr 20224809
May 20221800
Jun 20223603
Jul 20222001
Aug 20226204
Sep 20225005
Oct 20222401
Nov 20223805
Dec 20223001
Jan 20234802
Feb 20234405
Mar 20234403
Apr 20233601
May 20233207
Jun 20232604
Jul 20234405
Aug 20234006
Sep 20231602
Oct 20234405
Nov 20234009
Dec 20236402
Jan 20244602
Feb 20246802
Mar 20244805
Total18590274